FOR IMMEDIATE RELEASE: November 11, 2009


Tressa Kirby

On the Road to the Cure: Innovation and Signature Treatments at Georgetown Lombardi

Washington, DC – How can counting cancer cells in the blood make a difference in treatment? Can a potent hormone that fuels some breast cancers be used to fire back against the disease? These critical questions are being answered via innovative laboratory and clinical research underway at Georgetown Lombardi Comprehensive Cancer Center. A renowned pharmacologist who discovered a leading treatment for cancer and a physician treating patients in cutting edge clinical trials will discuss these and other life-enhancing discoveries during Doctors Speak Out, a series of conversations with physicians and researchers on today’s most pressing health issues.

In this installment of the Doctors Speak Out series, a distinguished panel of Georgetown physicians and researchers will detail research and treatment customized to an individual’s unique body make-up and the emergence of “systems medicine” – an approach based on the interplay of genes, environment and high-tech computation. Other topics include ways of expediting laboratory discoveries to benefit cancer patients, a new emphasis on preventative, holistic approaches to medicine, and the dawn of a retooled relationship of more equally shared responsibility between patient and physician.

WHERE: Georgetown University Conference Center, 3800 Reservoir Road, NW (Parking available at Hospital Entrance # 1)

WHEN: Thursday, Nov. 12, 2009; 12:00 – 1:30 pm
*Media must RSVP no later than Tuesday, Nov.11 by emailing/calling

WHO: Maureen Bunyan – Moderator; Anchor, WJLA-TV, Washington, D.C.

Howard J. Federoff, MD, PhD – Executive Vice President for Health Sciences at Georgetown University Medical Center, is an accomplished scientist and world-renowned expert in Alzheimer’s and Parkinson’s diseases.

V. Craig Jordan, OBE, PhD, DSc, FMedSci – Scientific director of the Lombardi Comprehensive Cancer Center and vice chair of the Department of Oncology, is widely regarded as the “father” of tamoxifen, having done the seminal work identifying this first ever treatment for breast cancer.

Minetta C. Liu, MD – Director of Translational Breast Cancer Research, Georgetown Lombardi Comprehensive Cancer Center, focuses her research primarily on the development of reliable predictors of treatment response in breast cancer.

About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through Georgetown’s affiliation with MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO), home to 60 percent of the university’s sponsored research funding.